Back
GeneDx Holdings Quote, Financials, Valuation and Earnings
Sponsored
WGS
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
39
WGS
GeneDx Holdings
Last Price:
38.77
Seasonality Move:
-56.15%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.GeneDx Holdings Price Quote
$38.77
+1.63 (+4.39%)
(Updated: September 18, 2024 at 6:55 PM ET)
GeneDx Holdings Key Stats
Sell
39
GeneDx Holdings (WGS)
is a Sell
Day range:
$37.00 - $38.29
52-week range:
$1.16 - $38.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.98
P/B ratio:
5.16%
Volume:
262.8K
Avg. volume:
353.1K
1-year change:
747.95%
Market cap:
$1B
Revenue:
$202.6M
EPS:
$-4.44
How Much Does GeneDx Holdings Make?
-
How Much Are GeneDx Holdings's Sales Annually?
WGS Revenues are $202.6M -
How Much Profit Does GeneDx Holdings's Make A Year?
WGS net income is -$175.8M
Is GeneDx Holdings Growing As A Company?
-
What Is GeneDx Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.45% -
What Is GeneDx Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
GeneDx Holdings Stock Price Performance
-
Did GeneDx Holdings Stock Go Up Last Month?
GeneDx Holdings share price went up by 7.43% last month -
Did WGS's Share Price Rise Over The Last Year?
WGS share price rose by 747.95% over the past 1 year
What Is GeneDx Holdings 52-Week High & Low?
-
What Is GeneDx Holdings’s 52-Week High Share Price?
GeneDx Holdings has traded as high as $38.95 over the past 52 weeks -
What Is GeneDx Holdings’s 52-Week Low Share Price?
GeneDx Holdings has traded as low as $1.16 over the past 52 weeks
GeneDx Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy GeneDx Holdings?
-
How Much Debt Does GeneDx Holdings Have?
Total long term debt quarterly is $52.2M -
How Much Cash Does GeneDx Holdings Have?
Cash and short term investments quarterly total is $106.9M -
What Is GeneDx Holdings’s Book Value Per Share?
Book value per share is 7.21
Is GeneDx Holdings Cash Flow Positive?
-
What Is WGS Cash Flow From Operations?
Cash flow from operations (TTM) is -$92M -
What Is GeneDx Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $45.4M -
What Is GeneDx Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$53.9M
GeneDx Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
WGS return on invested capital is -43.52% -
What Is GeneDx Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -28.02% -
What Is WGS Return On Equity?
ROE is a measure of profitability and is -49.79%
GeneDx Holdings Earnings Date & Stock Price
-
What Is GeneDx Holdings's Stock Price Today?
A single share of WGS can be purchased today for 37.14 -
What Is GeneDx Holdings’s Stock Symbol?
GeneDx Holdings trades on the nasdaq under the ticker symbol: WGS -
When Is GeneDx Holdings’s Next Earnings Date?
The next quarterly earnings date for GeneDx Holdings is scheduled on October 30, 2024 -
When Is WGS's next ex-dividend date?
GeneDx Holdings's next ex-dividend date is September 18, 2024 -
How To Buy GeneDx Holdings Stock?
You can buy GeneDx Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
GeneDx Holdings Competitors
-
Who Are GeneDx Holdings's Competitors?
Below is a list of companies who compete with GeneDx Holdings or are related in some way:
GeneDx Holdings Dividend Yield
-
What Is WGS Dividend Yield?
GeneDx Holdings’s dividend yield currently is 0% -
What Is GeneDx Holdings’s Payout Ratio?
GeneDx Holdings’s payout ratio is 0% -
When Did GeneDx Holdings Last Pay A Dividend?
The latest dividend pay date is September 18, 2024 -
What Is GeneDx Holdings’s Dividend Per Share?
GeneDx Holdings pays a dividend of $0.00 per share
GeneDx Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 65.7% |
Revenue: | 44.78% | 18.89% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 40.83 |
Upside from Last Price: | 9.94% |